<?xml version="1.0" encoding="utf-8"?>
<rss 
  version="2.0">
  <channel xmlns:dc="http://dublincore.org/documents/dcmi-namespace/" xmlns:media="http://search.yahoo.com/mrss/">
    <title>Cutting Edge Information</title>
    <link>https://www.globenewswire.com/rssfeed/organization/uNJ7mMloW7pC3RpeMQGCbg==</link>
    <description>Contains the last 20 releases</description>
    <copyright>Copyright 2017, Cutting Edge Information</copyright>
    <managingEditor>newsdesk@globenewswire.com (NewsDesk)</managingEditor>
    <lastBuildDate>Thu, 14 Sep 2017 22:51:00 GMT</lastBuildDate>
    <webMaster>webmaster@globenewswire.com (Webmaster)</webMaster>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2017/09/14/1181435/0/en/Most-Surveyed-Pharma-Companies-Choose-to-Fund-Dedicated-Continuing-Medical-Education-Programs.html</guid>
      <link>https://www.globenewswire.com/news-release/2017/09/14/1181435/0/en/Most-Surveyed-Pharma-Companies-Choose-to-Fund-Dedicated-Continuing-Medical-Education-Programs.html</link>
      <title>Most Surveyed Pharma Companies Choose to Fund Dedicated Continuing Medical Education Programs</title>
      <description><![CDATA[<p><span class="mw_region">RESEARCH TRIANGLE PARK, NC</span><span>--(Marketwired - September 14, 2017) - </span>About 77% of surveyed global medical affairs teams consider dedicated CME providers as their <a href="https://www.cuttingedgeinfo.com/2017/cme-providers/" rel="nofollow" title=""><span style="text-decoration:underline">first choice when funding continuing medical education (CME) programs</span></a>, according to a recent study by industry intelligence provider, Cutting Edge Information. </p>]]></description>
      <pubDate>Thu, 14 Sep 2017 22:51 GMT</pubDate>
      <dc:identifier>1181435</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cutting Edge Information</dc:contributor>
      <dc:modified>Wed, 14 Feb 2018 02:45 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="http://www.marketwire.com/library/MwGo/2017/8/9/11G143983/Images/September_14_2017_-_PH224_-_Most_Surveyed_Pharma_C-96e09e4609e38fcaa65d7c76b7d00a56.jpg">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2017/09/14/1181435/0/en/Most-Surveyed-Pharma-Companies-Choose-to-Fund-Dedicated-Continuing-Medical-Education-Programs.html">
    <img src="http://www.marketwire.com/library/MwGo/2017/8/9/11G143983/Images/September_14_2017_-_PH224_-_Most_Surveyed_Pharma_C-96e09e4609e38fcaa65d7c76b7d00a56.jpg" width="600" align="left" border="0" alt="medical education, continuing medical education, CME" title="Type of Organization to Which Teams Frequently Provide CME Funding" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:keyword>Medical education</dc:keyword>
      <dc:keyword>cutting edge information</dc:keyword>
      <dc:keyword>continuing medical education</dc:keyword>
      <dc:keyword>CME</dc:keyword>
      <dc:keyword>independent medical education</dc:keyword>
      <dc:keyword>IME</dc:keyword>
      <dc:keyword>company-driven medical education</dc:keyword>
      <dc:keyword>company-sponsored medical education</dc:keyword>
      <dc:keyword>CME provider</dc:keyword>
      <dc:keyword>budgeting</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2017/09/11/1181433/0/en/Lab-Animal-Sciences-Emerges-as-Most-Popular-Preclinical-Function-for-Surveyed-Global-Pharma-Teams.html</guid>
      <link>https://www.globenewswire.com/news-release/2017/09/11/1181433/0/en/Lab-Animal-Sciences-Emerges-as-Most-Popular-Preclinical-Function-for-Surveyed-Global-Pharma-Teams.html</link>
      <title>Lab Animal Sciences Emerges as Most Popular Preclinical Function for Surveyed Global Pharma Teams</title>
      <description><![CDATA[<p><span class="mw_region">RESEARCH TRIANGLE PARK, NC</span><span>--(Marketwired - September 11, 2017) - </span>New analysis of more than a dozen life science firms revealed that the highest percentage of surveyed global teams -- 91% -- involve <a href="https://www.cuttingedgeinfo.com/2017/product-portfolios/" rel="nofollow" title=""><span style="text-decoration:underline">lab animal science subgroups</span></a> in their preclinical structures, according to business intelligence provider Cutting Edge Information.</p>]]></description>
      <pubDate>Mon, 11 Sep 2017 23:42 GMT</pubDate>
      <dc:identifier>1181433</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cutting Edge Information</dc:contributor>
      <dc:modified>Wed, 14 Feb 2018 02:45 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="http://www.marketwire.com/library/MwGo/2017/8/9/11G143978/Images/September_11_2017_-_PH229_-_Lab_Animal_Sciences_Em-7b99b39c40d58fba9bf6c44a8ffb956c.jpg">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2017/09/11/1181433/0/en/Lab-Animal-Sciences-Emerges-as-Most-Popular-Preclinical-Function-for-Surveyed-Global-Pharma-Teams.html">
    <img src="http://www.marketwire.com/library/MwGo/2017/8/9/11G143978/Images/September_11_2017_-_PH229_-_Lab_Animal_Sciences_Em-7b99b39c40d58fba9bf6c44a8ffb956c.jpg" width="600" align="left" border="0" alt="clinical development, preclinical, pharmaceutical" title="Early-Stage Product Development: Strengthen Research and Development Outcomes with Robust Structures and Resources" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:keyword>preclinical</dc:keyword>
      <dc:keyword>toxicology</dc:keyword>
      <dc:keyword>early stage product development</dc:keyword>
      <dc:keyword>early stage drug development</dc:keyword>
      <dc:keyword>phase 0</dc:keyword>
      <dc:keyword>clinical development</dc:keyword>
      <dc:keyword>clinical trial planning</dc:keyword>
      <dc:keyword>preclinical drug development</dc:keyword>
      <dc:keyword>cutting edge information</dc:keyword>
      <dc:keyword>global pharma</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2017/09/07/1181442/0/en/Medical-Affairs-Teams-Typically-Start-Company-Driven-Medical-Education-Programs-During-Registration-and-Launch.html</guid>
      <link>https://www.globenewswire.com/news-release/2017/09/07/1181442/0/en/Medical-Affairs-Teams-Typically-Start-Company-Driven-Medical-Education-Programs-During-Registration-and-Launch.html</link>
      <title>Medical Affairs Teams Typically Start Company-Driven Medical Education Programs During Registration and Launch</title>
      <description><![CDATA[<p><span class="mw_region">RESEARCH TRIANGLE PARK, NC</span><span>--(Marketwired - September 06, 2017) - </span> New analysis of over a dozen life science firms found that 60% of surveyed teams begin <a href="https://www.cuttingedgeinfo.com/product/medical-education-programs/" rel="nofollow" title=""><span style="text-decoration:underline">company </span><span style="text-decoration:underline">driven </span><span style="text-decoration:underline">medical </span><span style="text-decoration:underline">education </span><span style="text-decoration:underline">activities</span></a> during the registration and launch phase, according to business intelligence provider Cutting Edge Information. </p>]]></description>
      <pubDate>Thu, 07 Sep 2017 00:12 GMT</pubDate>
      <dc:identifier>1181442</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cutting Edge Information</dc:contributor>
      <dc:modified>Wed, 14 Feb 2018 02:45 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="http://www.marketwire.com/library/MwGo/2017/8/11/11G144067/Images/September_6_2017_-_PH228_1.7_-_Medical_Affairs_Tea-2edb6b5208379931b6dab190321d0cfd.jpg">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2017/09/07/1181442/0/en/Medical-Affairs-Teams-Typically-Start-Company-Driven-Medical-Education-Programs-During-Registration-and-Launch.html">
    <img src="http://www.marketwire.com/library/MwGo/2017/8/11/11G144067/Images/September_6_2017_-_PH228_1.7_-_Medical_Affairs_Tea-2edb6b5208379931b6dab190321d0cfd.jpg" width="600" align="left" border="0" alt="company-driven medical education, medical education activities, medical education timeline" title="Company-Driven Medical Education Activity Start: Cumulative Percentage, by Product Type" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:keyword>medical affairs launch strategy</dc:keyword>
      <dc:keyword>medical science liaisons  MSLs</dc:keyword>
      <dc:keyword>medical communication</dc:keyword>
      <dc:keyword>medical publications</dc:keyword>
      <dc:keyword>medical information</dc:keyword>
      <dc:keyword>medical education</dc:keyword>
      <dc:keyword>cutting edge information</dc:keyword>
      <dc:keyword>company driven medical education</dc:keyword>
      <dc:keyword>medical education programs</dc:keyword>
      <dc:keyword>registration and launch phase</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2017/09/04/1181440/0/en/Study-Finds-Variations-in-Percentage-of-Clinical-Teams-Using-Simple-and-Complex-Adaptive-Trial-Designs.html</guid>
      <link>https://www.globenewswire.com/news-release/2017/09/04/1181440/0/en/Study-Finds-Variations-in-Percentage-of-Clinical-Teams-Using-Simple-and-Complex-Adaptive-Trial-Designs.html</link>
      <title>Study Finds Variations in Percentage of Clinical Teams Using Simple and Complex Adaptive Trial Designs</title>
      <description><![CDATA[<p><span class="mw_region">RESEARCH TRIANGLE PARK, NC</span><span>--(Marketwired - September 04, 2017) - </span>Recent analysis of clinical development teams show that surveyed clinical teams are divided on whether or not companies should concentrate their use of simple adaptive trial designs within Phases 2 and 3. </p>]]></description>
      <pubDate>Mon, 04 Sep 2017 23:16 GMT</pubDate>
      <dc:identifier>1181440</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cutting Edge Information</dc:contributor>
      <dc:modified>Wed, 14 Feb 2018 02:45 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="http://www.marketwire.com/library/MwGo/2017/8/11/11G144066/Images/September_4_2017_-_PH221_-_Study_Finds_Variations_-3b6aa9ba8753b77e9e1f2c171db65320.jpg">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2017/09/04/1181440/0/en/Study-Finds-Variations-in-Percentage-of-Clinical-Teams-Using-Simple-and-Complex-Adaptive-Trial-Designs.html">
    <img src="http://www.marketwire.com/library/MwGo/2017/8/11/11G144066/Images/September_4_2017_-_PH221_-_Study_Finds_Variations_-3b6aa9ba8753b77e9e1f2c171db65320.jpg" width="600" align="left" border="0" alt="clinical studies, clinical operations, clinical development, complex adaptive trials" title="Sponsor Organization Perspectives: Companies Should Concentrate Their Use of Complex Adaptive Trial Designs on Early-Stage Studies" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="http://www.marketwire.com/library/MwGo/2017/8/11/11G144066/Images/September_4_2017_-_PH221_-_Study_Finds_Variations_-6bb33d628afe97e487e273e409fe2300.jpg">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2017/09/04/1181440/0/en/Study-Finds-Variations-in-Percentage-of-Clinical-Teams-Using-Simple-and-Complex-Adaptive-Trial-Designs.html">
    <img src="http://www.marketwire.com/library/MwGo/2017/8/11/11G144066/Images/September_4_2017_-_PH221_-_Study_Finds_Variations_-6bb33d628afe97e487e273e409fe2300.jpg" width="600" align="left" border="0" alt="clinical trials, simple adaptive trials, simple adaptive trial design" title="Sponsor Organization Perspectives: Companies Should Concentrate on Using Simple Adaptive Trial Designs for Phases 2 and 3" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:keyword>Adaptive design clinical trials</dc:keyword>
      <dc:keyword>clinical trials</dc:keyword>
      <dc:keyword>cutting edge information</dc:keyword>
      <dc:keyword>adaptive trial design</dc:keyword>
      <dc:keyword>pharma trials</dc:keyword>
      <dc:keyword>clinical studies</dc:keyword>
      <dc:keyword>clinical operations</dc:keyword>
      <dc:keyword>clinical development</dc:keyword>
      <dc:keyword>group sequential</dc:keyword>
      <dc:keyword>adaptive randomization</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2017/08/31/1181437/0/en/Global-and-Regional-Level-Pharmaceutical-Market-Access-Teams-Plan-Early-to-Develop-Customized-Launch-Sequences.html</guid>
      <link>https://www.globenewswire.com/news-release/2017/08/31/1181437/0/en/Global-and-Regional-Level-Pharmaceutical-Market-Access-Teams-Plan-Early-to-Develop-Customized-Launch-Sequences.html</link>
      <title>Global and Regional Level Pharmaceutical Market Access Teams Plan Early to Develop Customized Launch Sequences</title>
      <description><![CDATA[<p><span class="mw_region">RESEARCH TRIANGLE PARK, NC</span><span>--(Marketwired - August 31, 2017) - </span> Surveyed teams at Top 10, Top 50 and small pharmaceutical companies each start their launch sequencing activities <a href="https://www.cuttingedgeinfo.com/2017/market-access-timelines/" rel="nofollow" title=""><span style="text-decoration:underline">an average of at least a year before products</span></a> are scheduled to launch, according to business intelligence firm Cutting Edge Information. </p>]]></description>
      <pubDate>Thu, 31 Aug 2017 19:41 GMT</pubDate>
      <dc:identifier>1181437</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cutting Edge Information</dc:contributor>
      <dc:modified>Wed, 14 Feb 2018 02:45 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="http://www.marketwire.com/library/MwGo/2017/8/11/11G144064/Images/August_31_2017_-_PH223_-_Global_and_Regional_Level-6a0a92dee2e3b58eba12ae32e25f19f0.jpg">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2017/08/31/1181437/0/en/Global-and-Regional-Level-Pharmaceutical-Market-Access-Teams-Plan-Early-to-Develop-Customized-Launch-Sequences.html">
    <img src="http://www.marketwire.com/library/MwGo/2017/8/11/11G144064/Images/August_31_2017_-_PH223_-_Global_and_Regional_Level-6a0a92dee2e3b58eba12ae32e25f19f0.jpg" width="600" align="left" border="0" alt="global market access, pharma, launch sequence, product launch timeline" title="Number of Months Before or After Product Launch for Start of Launch Sequencing Strategies, by Company Size" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:keyword>global market access</dc:keyword>
      <dc:keyword>market access structure</dc:keyword>
      <dc:keyword>market access budgets</dc:keyword>
      <dc:keyword>product launch</dc:keyword>
      <dc:keyword>launch sequencing</dc:keyword>
      <dc:keyword>market access strategy</dc:keyword>
      <dc:keyword>market access activities</dc:keyword>
      <dc:keyword>market access trends</dc:keyword>
      <dc:keyword>cutting edge information</dc:keyword>
      <dc:keyword>pharmaceutical market access</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2017/08/29/1181431/0/en/Pharma-Companies-Prefer-Not-to-Outsource-Call-Center-Staff-New-Study-Finds.html</guid>
      <link>https://www.globenewswire.com/news-release/2017/08/29/1181431/0/en/Pharma-Companies-Prefer-Not-to-Outsource-Call-Center-Staff-New-Study-Finds.html</link>
      <title>Pharma Companies Prefer Not to Outsource Call Center Staff, New Study Finds</title>
      <description><![CDATA[<p><em><p>Data show in-house medical information staff have more appeal for life science firms </p></em></p><p><span class="mw_region">RESEARCH TRIANGLE PARK, NC</span><span>--(Marketwired - August 29, 2017) - </span> A new study found that medical affairs teams prefer to rely on in-house rather than outsourced medical information full-time equivalents (FTEs), according to business intelligence provider Cutting Edge Information. </p>]]></description>
      <pubDate>Tue, 29 Aug 2017 23:23 GMT</pubDate>
      <dc:identifier>1181431</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cutting Edge Information</dc:contributor>
      <dc:modified>Wed, 14 Feb 2018 02:45 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="http://www.marketwire.com/library/MwGo/2017/8/9/11G143976/Images/August_29_2017_-_PH228_1.6_-_Pharma_Companies_Pref-4ad8f4c16827abad904a6ee0bfca90bd.jpg">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2017/08/29/1181431/0/en/Pharma-Companies-Prefer-Not-to-Outsource-Call-Center-Staff-New-Study-Finds.html">
    <img src="http://www.marketwire.com/library/MwGo/2017/8/9/11G143976/Images/August_29_2017_-_PH228_1.6_-_Pharma_Companies_Pref-4ad8f4c16827abad904a6ee0bfca90bd.jpg" width="600" align="left" border="0" alt="medical affairs, call center staffing, medical information" title="Medical Information Staff Outsourcing: First Year on Market" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:keyword>medical affairs launch strategy</dc:keyword>
      <dc:keyword>medical science liaisons  MSLs</dc:keyword>
      <dc:keyword>medical communication</dc:keyword>
      <dc:keyword>medical publications</dc:keyword>
      <dc:keyword>medical information</dc:keyword>
      <dc:keyword>medical education</dc:keyword>
      <dc:keyword>cutting edge information</dc:keyword>
      <dc:keyword>call centers</dc:keyword>
      <dc:keyword>staffing</dc:keyword>
      <dc:keyword>call center staff</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2017/08/25/1181428/0/en/More-Than-Half-of-Surveyed-Life-Science-Teams-Prefer-to-Centralize-Preclinical-Structures-Geographically.html</guid>
      <link>https://www.globenewswire.com/news-release/2017/08/25/1181428/0/en/More-Than-Half-of-Surveyed-Life-Science-Teams-Prefer-to-Centralize-Preclinical-Structures-Geographically.html</link>
      <title>More Than Half of Surveyed Life Science Teams Prefer to Centralize Preclinical Structures Geographically</title>
      <description><![CDATA[<p><span class="mw_region">RESEARCH TRIANGLE PARK, NC</span><span>--(Marketwired - August 25, 2017) - </span> A new study of <a href="https://cuttingedgeinfo.com/product/early-stage-product-development/" rel="nofollow" title=""><span style="text-decoration:underline">early-stage product development</span></a> teams found that the highest percentage of survey respondents – 62% – indicate that their preclinical function is geographically centralized. </p>]]></description>
      <pubDate>Fri, 25 Aug 2017 13:21 GMT</pubDate>
      <dc:identifier>1181428</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cutting Edge Information</dc:contributor>
      <dc:modified>Wed, 14 Feb 2018 02:45 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="http://www.marketwire.com/library/MwGo/2017/8/9/11G143972/Images/August_25_2017_-_PH229_-_More_Than_Half_of_Surveye-d26597f1e3069c59b54202080fe61044.jpg">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2017/08/25/1181428/0/en/More-Than-Half-of-Surveyed-Life-Science-Teams-Prefer-to-Centralize-Preclinical-Structures-Geographically.html">
    <img src="http://www.marketwire.com/library/MwGo/2017/8/9/11G143972/Images/August_25_2017_-_PH229_-_More_Than_Half_of_Surveye-d26597f1e3069c59b54202080fe61044.jpg" width="600" align="left" border="0" alt="preclinical, early stage product development, early stage drug development" title="Structure of Preclinical Function: All Surveyed Teams" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:keyword>preclinical</dc:keyword>
      <dc:keyword>toxicology</dc:keyword>
      <dc:keyword>early stage product development</dc:keyword>
      <dc:keyword>early stage drug development</dc:keyword>
      <dc:keyword>phase 0</dc:keyword>
      <dc:keyword>clinical development</dc:keyword>
      <dc:keyword>clinical trial planning</dc:keyword>
      <dc:keyword>academic-industry partnerships</dc:keyword>
      <dc:keyword>pharmaceutical development</dc:keyword>
      <dc:keyword>preclinical drug development</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2017/08/22/1181427/0/en/Percentage-of-In-Person-Medical-Education-Events-Surpass-Online-CME-Programs.html</guid>
      <link>https://www.globenewswire.com/news-release/2017/08/22/1181427/0/en/Percentage-of-In-Person-Medical-Education-Events-Surpass-Online-CME-Programs.html</link>
      <title>Percentage of In-Person Medical Education Events Surpass Online CME Programs</title>
      <description><![CDATA[<p><span class="mw_region">RESEARCH TRIANGLE PARK, NC</span><span>--(Marketwired - August 22, 2017) - </span> All surveyed US medical affairs teams dedicate on average over 65% of their continuing medical education (CME) funding to a mixture of small, mid-size and large in-person programs, according to a study by pharmaceutical intelligence provider, Cutting Edge Information. </p>]]></description>
      <pubDate>Tue, 22 Aug 2017 22:53 GMT</pubDate>
      <dc:identifier>1181427</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cutting Edge Information</dc:contributor>
      <dc:modified>Wed, 14 Feb 2018 02:45 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="http://www.marketwire.com/library/MwGo/2017/8/9/11G143970/Images/August_22_2017_-_PH224_-_Percentage_of_In-Person_M-6733a01e6b138392ac9c0dd04c9ceaa7.jpg">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2017/08/22/1181427/0/en/Percentage-of-In-Person-Medical-Education-Events-Surpass-Online-CME-Programs.html">
    <img src="http://www.marketwire.com/library/MwGo/2017/8/9/11G143970/Images/August_22_2017_-_PH224_-_Percentage_of_In-Person_M-6733a01e6b138392ac9c0dd04c9ceaa7.jpg" width="600" align="left" border="0" alt="company-driven medical education, company-sponsored medical education, CME provider," title="Percentage of CME Grants Funding Different Types of Events: US Teams" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="http://www.marketwire.com/library/MwGo/2017/8/9/11G143970/Images/August_22_2017_-_PH224_-_Percentage_of_In-Person_M-06e4f3eaeda48c218dcbfd5b08ebf907.jpg">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2017/08/22/1181427/0/en/Percentage-of-In-Person-Medical-Education-Events-Surpass-Online-CME-Programs.html">
    <img src="http://www.marketwire.com/library/MwGo/2017/8/9/11G143970/Images/August_22_2017_-_PH224_-_Percentage_of_In-Person_M-06e4f3eaeda48c218dcbfd5b08ebf907.jpg" width="600" align="left" border="0" alt="medical education, continuing medical education" title="Percentage of CME Grants Funding Different Types of Events: Global Teams" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:keyword>medical education</dc:keyword>
      <dc:keyword>cutting edge information</dc:keyword>
      <dc:keyword>continuing medical education</dc:keyword>
      <dc:keyword>CME</dc:keyword>
      <dc:keyword>independent medical education</dc:keyword>
      <dc:keyword>IME</dc:keyword>
      <dc:keyword>company-driven medical education</dc:keyword>
      <dc:keyword>company-sponsored medical education</dc:keyword>
      <dc:keyword>CME provider</dc:keyword>
      <dc:keyword>IME provider</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2017/08/16/1181422/0/en/Patients-Are-Not-the-1-Target-for-Social-Media-Other-Digital-Marketing-Strategies-New-Study-Finds.html</guid>
      <link>https://www.globenewswire.com/news-release/2017/08/16/1181422/0/en/Patients-Are-Not-the-1-Target-for-Social-Media-Other-Digital-Marketing-Strategies-New-Study-Finds.html</link>
      <title>Patients Are Not the #1 Target for Social Media &amp; Other Digital Marketing Strategies, New Study Finds</title>
      <description><![CDATA[<p><span class="mw_region">RESEARCH TRIANGLE PARK, NC</span><span>--(Marketwired - August 16, 2017) - </span> A new study of pharmaceutical marketing teams found that the primary digital strategy priority is to educate and communicate with physicians, making communication with patients across digital platforms a secondary priority. </p>]]></description>
      <pubDate>Wed, 16 Aug 2017 21:42 GMT</pubDate>
      <dc:identifier>1181422</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cutting Edge Information</dc:contributor>
      <dc:modified>Wed, 14 Feb 2018 02:45 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="http://www.marketwire.com/library/MwGo/2017/8/9/11G143964/Images/mw1bn449u8bnr11i7rnk4cjh1b4e2-4df367f1d9fba6299a983e72a0c36039.jpg">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2017/08/16/1181422/0/en/Patients-Are-Not-the-1-Target-for-Social-Media-Other-Digital-Marketing-Strategies-New-Study-Finds.html">
    <img src="http://www.marketwire.com/library/MwGo/2017/8/9/11G143964/Images/mw1bn449u8bnr11i7rnk4cjh1b4e2-4df367f1d9fba6299a983e72a0c36039.jpg" width="600" align="left" border="0" alt="social media, pharma marketing, patient objectives, patient communication" title="Social Media and Mobile Objectives" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="http://www.marketwire.com/library/MwGo/2017/8/9/11G143964/Images/mw1bn448lg21lhk164l1jr24gmk22-a513ffbffadf962cbb3ee8d830d4cb07.jpg">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2017/08/16/1181422/0/en/Patients-Are-Not-the-1-Target-for-Social-Media-Other-Digital-Marketing-Strategies-New-Study-Finds.html">
    <img src="http://www.marketwire.com/library/MwGo/2017/8/9/11G143964/Images/mw1bn448lg21lhk164l1jr24gmk22-a513ffbffadf962cbb3ee8d830d4cb07.jpg" width="600" align="left" border="0" alt="pharmaceutical marketing, digital marketing, marketing trends" title="Primary Target Users for Teams' Mobile Apps" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:keyword>pharmaceutical marketing</dc:keyword>
      <dc:keyword>pharma marketing strategy</dc:keyword>
      <dc:keyword>social media</dc:keyword>
      <dc:keyword>digital marketing</dc:keyword>
      <dc:keyword>cutting edge information</dc:keyword>
      <dc:keyword>pharma marketing</dc:keyword>
      <dc:keyword>patient communication</dc:keyword>
      <dc:keyword>digital trends</dc:keyword>
      <dc:keyword>marketing trends</dc:keyword>
      <dc:keyword>pharmaceutical industry trends</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2017/08/15/1181424/0/en/The-Most-Popular-Phase-of-Product-Development-for-Starting-Medical-Publications-Activities.html</guid>
      <link>https://www.globenewswire.com/news-release/2017/08/15/1181424/0/en/The-Most-Popular-Phase-of-Product-Development-for-Starting-Medical-Publications-Activities.html</link>
      <title>The Most Popular Phase of Product Development for Starting Medical Publications Activities</title>
      <description><![CDATA[<p align="left"><span class="mw_region">RESEARCH TRIANGLE PARK, NC</span><span>--(Marketwired - August 14, 2017) - </span>A new study by business intelligence provider Cutting Edge Information found that the highest percentage of surveyed life science teams (30%) delay medical publications activities <a href="https://www.cuttingedgeinfo.com/2017/medical-publications-strategies/" rel="nofollow" title=""><span style="text-decoration:underline">until products enter the registration and launch phase</span></a> of product development.</p>]]></description>
      <pubDate>Tue, 15 Aug 2017 00:42 GMT</pubDate>
      <dc:identifier>1181424</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cutting Edge Information</dc:contributor>
      <dc:modified>Wed, 14 Feb 2018 02:45 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="http://www.marketwire.com/library/MwGo/2017/8/9/11G143967/Images/August_14_2017_-_PH228_1.5_-_The_Most_Popular_Phas-51c294654bfcb3d5a7ee4c8dc21e14c1.jpg">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2017/08/15/1181424/0/en/The-Most-Popular-Phase-of-Product-Development-for-Starting-Medical-Publications-Activities.html">
    <img src="http://www.marketwire.com/library/MwGo/2017/8/9/11G143967/Images/August_14_2017_-_PH228_1.5_-_The_Most_Popular_Phas-51c294654bfcb3d5a7ee4c8dc21e14c1.jpg" width="600" align="left" border="0" alt="medical publications, medical affairs" title="Lifecycle Stage When Medical Publications Activities Start: All Teams" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:keyword>medical publications</dc:keyword>
      <dc:keyword>medical affairs</dc:keyword>
      <dc:keyword>medical abstracts</dc:keyword>
      <dc:keyword>cutting edge information</dc:keyword>
      <dc:keyword>medical affairs launch strategy</dc:keyword>
      <dc:keyword>medical communication</dc:keyword>
      <dc:keyword>medical education</dc:keyword>
      <dc:keyword>product development</dc:keyword>
      <dc:keyword>medical publication activities</dc:keyword>
      <dc:keyword>medical affairs trends</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2017/08/11/1181419/0/en/World-Class-Medical-Affairs-The-Top-3-Changes-Thought-Leaders-Want-from-Interactions-with-MSLs.html</guid>
      <link>https://www.globenewswire.com/news-release/2017/08/11/1181419/0/en/World-Class-Medical-Affairs-The-Top-3-Changes-Thought-Leaders-Want-from-Interactions-with-MSLs.html</link>
      <title>World-Class Medical Affairs: The Top 3 Changes Thought Leaders Want from Interactions with MSLs</title>
      <description><![CDATA[<p><span class="mw_region">RESEARCH TRIANGLE PARK, NC</span><span>--(Marketwired - August 11, 2017) - </span> New industry research on global medical affairs teams found that the top three changes key opinion leaders (KOLs) desire from medical science liaisons (MSLs) are knowing the right person to contact, better communication and having fewer contact points. </p>]]></description>
      <pubDate>Fri, 11 Aug 2017 14:12 GMT</pubDate>
      <dc:identifier>1181419</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cutting Edge Information</dc:contributor>
      <dc:modified>Wed, 14 Feb 2018 02:45 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="http://www.marketwire.com/library/MwGo/2017/8/7/11G143798/Images/August_11_2017_-_PH240_-_World-Class_Medical_Affai-2af6165bd400962eb336758f2f97d433.jpg">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2017/08/11/1181419/0/en/World-Class-Medical-Affairs-The-Top-3-Changes-Thought-Leaders-Want-from-Interactions-with-MSLs.html">
    <img src="http://www.marketwire.com/library/MwGo/2017/8/7/11G143798/Images/August_11_2017_-_PH240_-_World-Class_Medical_Affai-2af6165bd400962eb336758f2f97d433.jpg" width="600" align="left" border="0" alt="key opinion leaders, thought leader relationships, thought leaders, medical science liaisons" title="Desired Changes for MSL Interactions: All Surveyed Thought Leaders" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:keyword>key opinion leaders</dc:keyword>
      <dc:keyword>thought leader relationships</dc:keyword>
      <dc:keyword>thought leaders</dc:keyword>
      <dc:keyword>medical science liaisons</dc:keyword>
      <dc:keyword>cutting edge information</dc:keyword>
      <dc:keyword>medical affairs</dc:keyword>
      <dc:keyword>KOLs</dc:keyword>
      <dc:keyword>MSLs</dc:keyword>
      <dc:keyword>KOL relationships</dc:keyword>
      <dc:keyword>key opinion leader relationships</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2017/08/09/1181417/0/en/The-Most-Popular-Social-Media-Platforms-in-the-Pharma-Industry-for-2017-2018.html</guid>
      <link>https://www.globenewswire.com/news-release/2017/08/09/1181417/0/en/The-Most-Popular-Social-Media-Platforms-in-the-Pharma-Industry-for-2017-2018.html</link>
      <title>The Most Popular Social Media Platforms in the Pharma Industry for 2017 &amp; 2018</title>
      <description><![CDATA[<p><span class="mw_region">RESEARCH TRIANGLE PARK, NC</span><span>--(Marketwired - August 09, 2017) - </span> A new study of <a href="https://www.cuttingedgeinfo.com/product/pharmaceutical-marketing/" rel="nofollow" title=""><span style="text-decoration:underline">pharmaceutical marketing</span></a> teams found that the most popular social media forum groups plan to use in the next one to two years is <a href="https://www.facebook.com/" rel="nofollow" title=""><span style="text-decoration:underline">Facebook</span></a> (73%), according to data published by <a href="https://www.cuttingedgeinfo.com/" rel="nofollow" title=""><span style="text-decoration:underline">business intelligence firm</span></a> Cutting Edge Information.</p>]]></description>
      <pubDate>Wed, 09 Aug 2017 21:56 GMT</pubDate>
      <dc:identifier>1181417</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cutting Edge Information</dc:contributor>
      <dc:modified>Wed, 14 Feb 2018 02:45 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="http://www.marketwire.com/library/MwGo/2017/8/7/11G143795/Images/mw1bmuv9bqr5vm17ro18kk1hf41kp02-a7c5c94930298075873ceef59524891d.jpg">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2017/08/09/1181417/0/en/The-Most-Popular-Social-Media-Platforms-in-the-Pharma-Industry-for-2017-2018.html">
    <img src="http://www.marketwire.com/library/MwGo/2017/8/7/11G143795/Images/mw1bmuv9bqr5vm17ro18kk1hf41kp02-a7c5c94930298075873ceef59524891d.jpg" width="600" align="left" border="0" alt="pharmaceutical marketing, pharma marketing, social media, digital platforms" title="Social Media Forums Teams Are Using Within Next 1-2 Years" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:keyword>pharmaceutical marketing</dc:keyword>
      <dc:keyword>pharma marketing</dc:keyword>
      <dc:keyword>social media</dc:keyword>
      <dc:keyword>digital platforms</dc:keyword>
      <dc:keyword>cutting edge information</dc:keyword>
      <dc:keyword>social networking sites</dc:keyword>
      <dc:keyword>social networking</dc:keyword>
      <dc:keyword>digital strategy</dc:keyword>
      <dc:keyword>digital pharma</dc:keyword>
      <dc:keyword>social media platforms</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2017/08/08/1181416/0/en/Digital-Communication-is-the-1-Method-for-Pharma-Field-Forces-When-Interacting-With-External-Stakeholders.html</guid>
      <link>https://www.globenewswire.com/news-release/2017/08/08/1181416/0/en/Digital-Communication-is-the-1-Method-for-Pharma-Field-Forces-When-Interacting-With-External-Stakeholders.html</link>
      <title>Digital Communication is the # 1 Method for Pharma Field Forces When Interacting With External Stakeholders</title>
      <description><![CDATA[<p><span class="mw_region">RESEARCH TRIANGLE PARK, NC</span><span>--(Marketwired - August 08, 2017) - </span>The majority of interactions between surveyed health economics (HE) field force teams and external stakeholders <a href="https://www.cuttingedgeinfo.com/2017/new-engagement-platforms/" rel="nofollow" title=""><span style="text-decoration:underline">occur through email correspondence</span></a>, rather than face-to-face and phone interactions, according to a new study by business intelligence provider Cutting Edge Information. </p>]]></description>
      <pubDate>Tue, 08 Aug 2017 23:16 GMT</pubDate>
      <dc:identifier>1181416</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cutting Edge Information</dc:contributor>
      <dc:modified>Wed, 14 Feb 2018 02:45 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="http://www.marketwire.com/library/MwGo/2017/8/7/11G143794/Images/August_8_2017_-_PH227_-_Digital_Communication_is_t-c73f035b04f9a6d594fbe6a6474f3879.jpg">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2017/08/08/1181416/0/en/Digital-Communication-is-the-1-Method-for-Pharma-Field-Forces-When-Interacting-With-External-Stakeholders.html">
    <img src="http://www.marketwire.com/library/MwGo/2017/8/7/11G143794/Images/August_8_2017_-_PH227_-_Digital_Communication_is_t-c73f035b04f9a6d594fbe6a6474f3879.jpg" width="600" align="left" border="0" alt="health outcomes liaisons, field force data" title="Median Percentage of Health Economics Field Force Interactions, by Type and Target" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="http://www.marketwire.com/library/MwGo/2017/8/7/11G143794/Images/August_8_2017_-_PH227_-_Digital_Communication_is_t-dba5ac39f5d1a01cabcf4cf624073594.jpg">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2017/08/08/1181416/0/en/Digital-Communication-is-the-1-Method-for-Pharma-Field-Forces-When-Interacting-With-External-Stakeholders.html">
    <img src="http://www.marketwire.com/library/MwGo/2017/8/7/11G143794/Images/August_8_2017_-_PH227_-_Digital_Communication_is_t-dba5ac39f5d1a01cabcf4cf624073594.jpg" width="600" align="left" border="0" alt="health economics field forces, he field forces, digital communication" title="Average Percentage of Health Economics Field Force Interactions, by Type and Target" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:keyword>health economics field forces</dc:keyword>
      <dc:keyword>he field forces</dc:keyword>
      <dc:keyword>cutting edge information</dc:keyword>
      <dc:keyword>field force data</dc:keyword>
      <dc:keyword>health outcomes liaisons</dc:keyword>
      <dc:keyword>market access field forces</dc:keyword>
      <dc:keyword>digital communication</dc:keyword>
      <dc:keyword>medical affairs</dc:keyword>
      <dc:keyword>health economics</dc:keyword>
      <dc:keyword>health economics data</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2017/08/03/1181414/0/en/Planning-For-Medical-Education-Programs-Range-From-Merely-Two-Hours-to-a-Whopping-400-Hours.html</guid>
      <link>https://www.globenewswire.com/news-release/2017/08/03/1181414/0/en/Planning-For-Medical-Education-Programs-Range-From-Merely-Two-Hours-to-a-Whopping-400-Hours.html</link>
      <title>Planning For Medical Education Programs Range From Merely Two Hours to a Whopping 400 Hours</title>
      <description><![CDATA[<p><em><p>Time spent planning events and reviewing materials depends on product type and event type, study finds </p></em></p><p><span class="mw_region">RESEARCH TRIANGLE PARK, NC</span><span>--(Marketwired - August 03, 2017) - </span> Planning an in-person medical education event can take anywhere from a mere two hours to an incredible 400 hours among surveyed Top 10, Top 50, and small pharmaceutical companies, according to data recently published by <a href="https://www.cuttingedgeinfo.com/" rel="nofollow" title=""><span style="text-decoration:underline">business intelligence firm</span></a> Cutting Edge Information. </p>]]></description>
      <pubDate>Thu, 03 Aug 2017 19:28 GMT</pubDate>
      <dc:identifier>1181414</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cutting Edge Information</dc:contributor>
      <dc:modified>Wed, 14 Feb 2018 02:45 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="http://www.marketwire.com/library/MwGo/2017/8/2/11G143629/Images/August_3_2017_-_PH224_-_Planning_for_Medical_Educa-baef1c12758a8a018f35201aa913725b.jpg">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2017/08/03/1181414/0/en/Planning-For-Medical-Education-Programs-Range-From-Merely-Two-Hours-to-a-Whopping-400-Hours.html">
    <img src="http://www.marketwire.com/library/MwGo/2017/8/2/11G143629/Images/August_3_2017_-_PH224_-_Planning_for_Medical_Educa-baef1c12758a8a018f35201aa913725b.jpg" width="600" align="left" border="0" alt="medical education, reviewing medical education materials, planning medical education events" title="Average Number of Hours Spent Reviewing Materials and Planning an Event" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:keyword>Medical education</dc:keyword>
      <dc:keyword>cutting edge information</dc:keyword>
      <dc:keyword>continuing medical education</dc:keyword>
      <dc:keyword>CME</dc:keyword>
      <dc:keyword>independent medical education</dc:keyword>
      <dc:keyword>IME</dc:keyword>
      <dc:keyword>company-driven medical education</dc:keyword>
      <dc:keyword>company-sponsored medical education</dc:keyword>
      <dc:keyword>CME provider</dc:keyword>
      <dc:keyword>IME provider</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2017/08/02/1181411/0/en/Only-22-of-Adherence-Teams-Work-With-Patients-During-Early-Clinical-Stages-of-Product-Development.html</guid>
      <link>https://www.globenewswire.com/news-release/2017/08/02/1181411/0/en/Only-22-of-Adherence-Teams-Work-With-Patients-During-Early-Clinical-Stages-of-Product-Development.html</link>
      <title>Only 22% of Adherence Teams Work With Patients During Early Clinical Stages of Product Development</title>
      <description><![CDATA[<p><em><p>More than half of teams initiate patient activities during Phase 3 or registration and launch </p></em></p><p><span class="mw_region">RESEARCH TRIANGLE PARK, NC</span><span>--(Marketwired - August 02, 2017) - </span> The highest percentage of surveyed life science teams -- 66% -- begin patient adherence activities during either Phase 3 of product development or the registration and launch window, according to pharmaceutical intelligence firm Cutting Edge Information. </p>]]></description>
      <pubDate>Wed, 02 Aug 2017 21:38 GMT</pubDate>
      <dc:identifier>1181411</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cutting Edge Information</dc:contributor>
      <dc:modified>Wed, 14 Feb 2018 02:45 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="http://www.marketwire.com/library/MwGo/2017/7/28/11G143377/Images/August_2_2017_-_PH226_-_Only_22_Percent_of_Adheren-fb6f4c626160b5c88c7b7ae4073789d2.jpg">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2017/08/02/1181411/0/en/Only-22-of-Adherence-Teams-Work-With-Patients-During-Early-Clinical-Stages-of-Product-Development.html">
    <img src="http://www.marketwire.com/library/MwGo/2017/7/28/11G143377/Images/August_2_2017_-_PH226_-_Only_22_Percent_of_Adheren-fb6f4c626160b5c88c7b7ae4073789d2.jpg" width="600" align="left" border="0" alt="patient adherence activities, patient compliance, patient adherence teams" title="Product Lifecycle Stage When Firms Begin Patient Adherence Activities, by Company Size" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="http://www.marketwire.com/library/MwGo/2017/7/28/11G143377/Images/August_2_2017_-_PH226_-_Only_22_Percent_of_Adheren-3dee5de34f1bb89d84bdcbb1cb5a833c.jpg">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2017/08/02/1181411/0/en/Only-22-of-Adherence-Teams-Work-With-Patients-During-Early-Clinical-Stages-of-Product-Development.html">
    <img src="http://www.marketwire.com/library/MwGo/2017/7/28/11G143377/Images/August_2_2017_-_PH226_-_Only_22_Percent_of_Adheren-3dee5de34f1bb89d84bdcbb1cb5a833c.jpg" width="600" align="left" border="0" alt="patient adherence, clinical stages, product lifecycle" title="Product Lifecycle Stage When Firms Begin Patient Organization Activities, by Company Size" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:keyword>patient adherence</dc:keyword>
      <dc:keyword>clinical stages</dc:keyword>
      <dc:keyword>product lifecycle</dc:keyword>
      <dc:keyword>cutting edge information</dc:keyword>
      <dc:keyword>patient adherence activities</dc:keyword>
      <dc:keyword>patient compliance</dc:keyword>
      <dc:keyword>patient communication</dc:keyword>
      <dc:keyword>phase 3</dc:keyword>
      <dc:keyword>patient adherence initiatives</dc:keyword>
      <dc:keyword>pharmaceutical industry</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2017/07/31/1181408/0/en/The-Top-3-Pharma-Functions-Involved-in-Patient-Centric-Initiatives-Apart-from-Marketing.html</guid>
      <link>https://www.globenewswire.com/news-release/2017/07/31/1181408/0/en/The-Top-3-Pharma-Functions-Involved-in-Patient-Centric-Initiatives-Apart-from-Marketing.html</link>
      <title>The Top 3 Pharma Functions Involved in Patient-Centric Initiatives (Apart from Marketing)</title>
      <description><![CDATA[<p><span class="mw_region">RESEARCH TRIANGLE PARK, NC</span><span>--(Marketwired - July 31, 2017) - </span>Apart from marketing, the most popular functions that are involved in at least 65% of surveyed patient-centric initiatives are brand team, legal/regulatory affairs and medical affairs, according to a recent study by pharmaceutical intelligence provider Cutting Edge Information. </p>]]></description>
      <pubDate>Mon, 31 Jul 2017 20:44 GMT</pubDate>
      <dc:identifier>1181408</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cutting Edge Information</dc:contributor>
      <dc:modified>Wed, 14 Feb 2018 02:45 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="http://www.marketwire.com/library/MwGo/2017/7/28/11G143374/Images/July_31_2017_-_PH222_-_The_Top_3_Pharma_Functions_-3009fe29cf4c84529d32b3a759b6baa5.jpg">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2017/07/31/1181408/0/en/The-Top-3-Pharma-Functions-Involved-in-Patient-Centric-Initiatives-Apart-from-Marketing.html">
    <img src="http://www.marketwire.com/library/MwGo/2017/7/28/11G143374/Images/July_31_2017_-_PH222_-_The_Top_3_Pharma_Functions_-3009fe29cf4c84529d32b3a759b6baa5.jpg" width="600" align="left" border="0" alt="patient centric, patient centricity, marketing, patient centric initiatives" title="Image: Functions Involved With Patient-Centric Initiatives" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:keyword>Patient centricity</dc:keyword>
      <dc:keyword>patient centric</dc:keyword>
      <dc:keyword>Cutting Edge Information</dc:keyword>
      <dc:keyword>patient engagement</dc:keyword>
      <dc:keyword>patient-centric marketing</dc:keyword>
      <dc:keyword>patient education</dc:keyword>
      <dc:keyword>measuring patient engagement</dc:keyword>
      <dc:keyword>patient outreach</dc:keyword>
      <dc:keyword>marketing</dc:keyword>
      <dc:keyword>patient centric initiatives</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2017/07/25/1181406/0/en/Top-Pharma-Companies-Now-Include-Communicating-HEOR-Data-as-a-Part-of-Their-Medical-Affairs-Strategy.html</guid>
      <link>https://www.globenewswire.com/news-release/2017/07/25/1181406/0/en/Top-Pharma-Companies-Now-Include-Communicating-HEOR-Data-as-a-Part-of-Their-Medical-Affairs-Strategy.html</link>
      <title>Top Pharma Companies Now Include Communicating HEOR Data as a Part of Their Medical Affairs Strategy</title>
      <description><![CDATA[<p><span class="mw_region">RESEARCH TRIANGLE PARK, NC</span><span>--(Marketwired - July 25, 2017) - </span>New analysis of Top 10, Top 50 and small medical device companies revealed that health economics and outcomes research (HEOR) data is increasingly becoming a part of surveyed medical affairs teams' strategies, according to <a href="https://www.cuttingedgeinfo.com/" rel="nofollow" title=""><span style="text-decoration:underline">pharmaceutical business intelligence firm</span></a> Cutting Edge Information. </p>]]></description>
      <pubDate>Tue, 25 Jul 2017 21:42 GMT</pubDate>
      <dc:identifier>1181406</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cutting Edge Information</dc:contributor>
      <dc:modified>Wed, 14 Feb 2018 02:45 GMT</dc:modified>
      <dc:keyword>medical affairs launch strategy</dc:keyword>
      <dc:keyword>medical communication</dc:keyword>
      <dc:keyword>medical information</dc:keyword>
      <dc:keyword>medical education</dc:keyword>
      <dc:keyword>health economics and outcomes research</dc:keyword>
      <dc:keyword>HEOR data</dc:keyword>
      <dc:keyword>health economics and outcomes research data</dc:keyword>
      <dc:keyword>HEOR</dc:keyword>
      <dc:keyword>health outcomes research</dc:keyword>
      <dc:keyword>cutting edge information</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2017/07/24/1181404/0/en/Top-Pharma-Companies-Nurture-Relationships-with-Payers-Before-During-and-After-Launch-to-Ensure-and-Retain-Market-Access.html</guid>
      <link>https://www.globenewswire.com/news-release/2017/07/24/1181404/0/en/Top-Pharma-Companies-Nurture-Relationships-with-Payers-Before-During-and-After-Launch-to-Ensure-and-Retain-Market-Access.html</link>
      <title>Top Pharma Companies Nurture Relationships with Payers Before, During and After Launch to Ensure and Retain Market Access</title>
      <description><![CDATA[<p><span class="mw_region">RESEARCH TRIANGLE PARK, NC</span><span>--(Marketwired - July 24, 2017) - </span>Payer relationship management accounts for an average of 26% of surveyed global pharmaceutical and medical device companies' total market access budget, according to a recent study by business intelligence provider Cutting Edge Information. </p>]]></description>
      <pubDate>Mon, 24 Jul 2017 22:54 GMT</pubDate>
      <dc:identifier>1181404</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cutting Edge Information</dc:contributor>
      <dc:modified>Wed, 14 Feb 2018 02:45 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="http://www.marketwire.com/library/MwGo/2017/7/21/11G143058/Images/July_24_2017_-_PH223_-_Top_Pharma_Companies_Nurtur-a4b1f1f3bd03ae5a92f7cc0b0f7298ba.jpg">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2017/07/24/1181404/0/en/Top-Pharma-Companies-Nurture-Relationships-with-Payers-Before-During-and-After-Launch-to-Ensure-and-Retain-Market-Access.html">
    <img src="http://www.marketwire.com/library/MwGo/2017/7/21/11G143058/Images/July_24_2017_-_PH223_-_Top_Pharma_Companies_Nurtur-a4b1f1f3bd03ae5a92f7cc0b0f7298ba.jpg" width="600" align="left" border="0" alt="Global market access, market access strategy, payer relationship management, market access budget" title="Percentage of Budget and FTEs Allocated to Market Access Administration and Payer Relationships" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:keyword>global market access</dc:keyword>
      <dc:keyword>market access strategy</dc:keyword>
      <dc:keyword>payer relationship management</dc:keyword>
      <dc:keyword>market access spending</dc:keyword>
      <dc:keyword>market access budgets</dc:keyword>
      <dc:keyword>cutting edge information</dc:keyword>
      <dc:keyword>payer relationships</dc:keyword>
      <dc:keyword>market access</dc:keyword>
      <dc:keyword>payer requirements</dc:keyword>
      <dc:keyword>pharmaceutical market access</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2017/07/19/1181401/0/en/Clinical-Teams-From-Top-Pharma-Companies-Are-Overcoming-Challenges-in-Planning-and-Implementing-Adaptive-Trial-Design-Studies.html</guid>
      <link>https://www.globenewswire.com/news-release/2017/07/19/1181401/0/en/Clinical-Teams-From-Top-Pharma-Companies-Are-Overcoming-Challenges-in-Planning-and-Implementing-Adaptive-Trial-Design-Studies.html</link>
      <title>Clinical Teams From Top Pharma Companies Are Overcoming Challenges in Planning and Implementing Adaptive Trial Design Studies</title>
      <description><![CDATA[<p><span class="mw_region">RESEARCH TRIANGLE PARK, NC</span><span>--(Marketwired - July 19, 2017) - </span>A recent study of Top 10, Top 50, and small medical device companies found that addressing regulators' concerns for late-stage studies is the most common challenge clinical development teams encounter during their adaptive trial design preparations, according to research published by business intelligence firm Cutting Edge Information. </p>]]></description>
      <pubDate>Wed, 19 Jul 2017 23:23 GMT</pubDate>
      <dc:identifier>1181401</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cutting Edge Information</dc:contributor>
      <dc:modified>Wed, 14 Feb 2018 02:45 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="http://www.marketwire.com/library/MwGo/2017/7/19/11G142952/Images/July_19_2017_-_PH221_-_Clinical_Teams_From_Top_Pha-dc3ff490440b8784a85640f9f9571f8c.jpg">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2017/07/19/1181401/0/en/Clinical-Teams-From-Top-Pharma-Companies-Are-Overcoming-Challenges-in-Planning-and-Implementing-Adaptive-Trial-Design-Studies.html">
    <img src="http://www.marketwire.com/library/MwGo/2017/7/19/11G142952/Images/July_19_2017_-_PH221_-_Clinical_Teams_From_Top_Pha-dc3ff490440b8784a85640f9f9571f8c.jpg" width="600" align="left" border="0" alt="clinical trials, adaptive trial design, clinical development" title="Average Rating of Execution-Based Adaptive Trial Design Challenges: All Surveyed Trial Sponsor Teams" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="http://www.marketwire.com/library/MwGo/2017/7/19/11G142952/Images/July_19_2017_-_PH221_-_Clinical_Teams_From_Top_Pha-bd6b21e0d9caa784ac0c15bac9319e21.jpg">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2017/07/19/1181401/0/en/Clinical-Teams-From-Top-Pharma-Companies-Are-Overcoming-Challenges-in-Planning-and-Implementing-Adaptive-Trial-Design-Studies.html">
    <img src="http://www.marketwire.com/library/MwGo/2017/7/19/11G142952/Images/July_19_2017_-_PH221_-_Clinical_Teams_From_Top_Pha-bd6b21e0d9caa784ac0c15bac9319e21.jpg" width="600" align="left" border="0" alt="adaptive design clinical trials, clinical studies, clinical operations" title="Average Rating of Planning-Based Adaptive Trial Design Challenges: All Surveyed Trial Sponsor Teams" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:keyword>Adaptive design clinical trials</dc:keyword>
      <dc:keyword>clinical trials</dc:keyword>
      <dc:keyword>cutting edge information</dc:keyword>
      <dc:keyword>adaptive trial design</dc:keyword>
      <dc:keyword>pharma trials</dc:keyword>
      <dc:keyword>clinical studies</dc:keyword>
      <dc:keyword>clinical operations</dc:keyword>
      <dc:keyword>clinical development</dc:keyword>
      <dc:keyword>group sequential</dc:keyword>
      <dc:keyword>adaptive randomization</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2017/07/13/1181399/0/en/About-67-of-Global-Market-Access-Teams-Meet-With-Regulatory-Groups-Weekly-When-Approaching-Product-Launch.html</guid>
      <link>https://www.globenewswire.com/news-release/2017/07/13/1181399/0/en/About-67-of-Global-Market-Access-Teams-Meet-With-Regulatory-Groups-Weekly-When-Approaching-Product-Launch.html</link>
      <title>About 67% of Global Market Access Teams Meet With Regulatory Groups Weekly When Approaching Product Launch</title>
      <description><![CDATA[<p><span class="mw_region">RESEARCH TRIANGLE PARK, NC</span><span>--(Marketwired - July 13, 2017) - </span>At least 67% of surveyed global market access teams meet with internal regulatory groups weekly in the six months before the first launch wave, according to a study by pharmaceutical intelligence firm Cutting Edge Information. </p>]]></description>
      <pubDate>Thu, 13 Jul 2017 12:45 GMT</pubDate>
      <dc:identifier>1181399</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cutting Edge Information</dc:contributor>
      <dc:modified>Wed, 14 Feb 2018 02:45 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="http://www.marketwire.com/library/MwGo/2017/7/10/11G142436/Images/July_13_2017_-_PH217_-_About_67_Percent_of_Global_-d0735c0b039b8188b9825744bb92185a.jpg">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2017/07/13/1181399/0/en/About-67-of-Global-Market-Access-Teams-Meet-With-Regulatory-Groups-Weekly-When-Approaching-Product-Launch.html">
    <img src="http://www.marketwire.com/library/MwGo/2017/7/10/11G142436/Images/July_13_2017_-_PH217_-_About_67_Percent_of_Global_-d0735c0b039b8188b9825744bb92185a.jpg" width="600" align="left" border="0" alt="Market access launch, market access launch strategy, launch sequencing" title="Frequency of Launch Team Meetings With Internal Regulatory Groups: Global Teams" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:keyword>Market access launch</dc:keyword>
      <dc:keyword>market access launch strategy</dc:keyword>
      <dc:keyword>launch sequencing</dc:keyword>
      <dc:keyword>launch window</dc:keyword>
      <dc:keyword>pharmaceutical launch excellence</dc:keyword>
      <dc:keyword>pharmaceutical product launch</dc:keyword>
      <dc:keyword>launch activities</dc:keyword>
      <dc:keyword>launch planning</dc:keyword>
      <dc:keyword>Cutting Edge Information</dc:keyword>
      <dc:keyword>pharmaceutical market access</dc:keyword>
    </item>
  </channel>
</rss>